The U.S. Food and Drug Administration (FDA) has issued a voluntary recall of several over-the-counter medications used to treat allergies after it was discovered that the tablets may have been cross-contaminated with another medication.
The regulatory authority revealed that Unique Pharmaceutical Laboratories recalled cetirizine hydrochloride tablets from the market after it was discovered that they may have been contaminated with ranitidine, a drug formerly known as Zantac.
The problem was realized when a pharmacy technician saw unusual red dots and discolored cetirizine hydrochloride tablets. Fortunately, so far no adverse incidents have been reported after consumption of the product.
The recall notice explains that some people who have high blood pressure due to the ingredients in ranitidine, a medication that blocks stomach fluids and is used to treat ulcers and heat burns, may experience serious health risks if they consume the cross-contaminated drug.
Possible side effects of taking the affected product can be life-threatening and include low blood pressure, difficulty breathing or swallowing, swelling of the throat and face, itchy skin, hives, and even loss of consciousness.
The recall involves bottles of 100 tablets distributed by Rising Pharma Holding Inc. nationwide. Here are the details:
Consumers are encouraged to contact Rising Pharma Holdings at 1-844-874-7464 during business hours or by email at [email protected] either [email protected] to get answers to your questions.
